Motor and Language Deficits Common in Children Evaluated for Autism
In a cross-sectional study, researchers explored the co-occurrence for motor and language impairments in children evaluated for autism.
All articles by Jessica Nye, PhD
No Evidence Computer Vision Syndrome Interventions Work
Computer-induced strain could not be overcome with any method, including the oft discussed 20/20/20 rule, a study shows.
Neurofilament Light Chain Levels May Predict Multiple Sclerosis Disease Activity
Presenting at CMSC 2022, researchers evaluated the prognostic value of baseline NfL for predicting clinical relapse and change in MRI lesion activity among patients with MS.
Effects of Antiseptic Mouth Rinses on COVID-19 Transmission
Researchers assessed the antiviral activity of several antiseptic agents against COVID-19 transmissibility.
The Risk for Guillain-Barré Syndrome Following J&J COVID-19 Vaccination
Researchers sought to assess the incidence of Guillain-Barré syndrome following vaccination for Ad.26.COV2.S (Janssen) and mRNA vaccines.
Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
Possible Causal Relationship Between COVID-19 and Gestational Diabetes Onset
Researchers assessed the prevalence of gestational diabetes among women with COVID-19 infection who were pregnant and the risk factors associated with severe disease.
Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Adjuvanted Enterovirus 71 Vaccine Is Highly Effective in Infants and Children
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Link Between Arthritis Drugs and Alzheimer Disease Risk
Researchers sought to evaluate whether there is any evidence from real-world data on treatment with tofacitinib, tocilizumab, or tumor necrosis factor and the risk for ADRD.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...